Global Isobutyl Benzene Market 2018-2022 | Increasing Prevalence of Migraine to Boost Growth | Technavio
LONDON--(BUSINESS WIRE)--Oct 3, 2018--The global isobutyl benzene market is expected to post a CAGR of over 4% during the period 2018-2022, according to the latest market research report by .
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181003005845/en/
Technavio has published a new market research report on the global isobutyl benzene market for the period 2018-2022. (Graphic: Business Wire)
A key factor driving the growth of the market is the high demand for ibuprofen. Isobutyl benzene is a major raw material used for manufacturing ibuprofen. Ibuprofen is an extensively used painkiller. It is an analgesic, anti-inflammatory drug used for treating rheumatoid arthritis, ankylosing spondylitis, osteoarthritis, and other non-rheumatoid arthritis. Ibuprofen can be used for treating soft-tissue injuries such as sprains and strains. It is a cost-effective analgesic and anti-inflammatory drug.
This market research report on the also provides an analysis of the most important trends expected to impact the market outlook during the forecast period. Technavio classifies an emerging trend as a major factor that has the potential to significantly impact the market and contribute to its growth or decline.
In this report, Technavio highlights the increasing prevalence of migraine as one of the key emerging trends in the global isobutyl benzene market:
Global isobutyl benzene market: Increasing prevalence of migraine
Headache disorder, including migraine, are some of the common disorders. Migraine is a major headache disorder that can cause significant disabilities such as visual disturbances and sensitivity to light, nose, and smell. It is the third-most prevalent illness in the world. Migraine most often begins at puberty and mostly affects people aged between 35-45 years. Women are known to be more affected by migraine than men because of hormonal influences. It affects twice as many women as men.
“The increasing number of migraine cases fuels the consumption of ibuprofen, as it relieves a migraine headache. Ibuprofen is typically used for short-term pain relief. It is used for preventing migraine attacks as well. The increasing prevalence of migraines and their serious effects on individuals accelerate the consumption of ibuprofen, thereby having a positive influence on the market,” says a senior analyst at Technavio for research on specialty chemicals.
Global isobutyl benzene market: Segmentation analysis
This market research report segments the global isobutyl benzene market by end-user (pharmaceuticals and others) and geographical regions (APAC, EMEA, and the Americas).
The pharmaceuticals segment held the largest market share in 2017, accounting for nearly 90% of the market. This application segment is expected to dominate the global market throughout the forecast period.
APAC led the market in 2017 with a market share of nearly 40%. This region is expected to dominate the market through 2022.
Technavio’s sample reports are free of charge and contain multiple sections of the report such as the market size and forecast, drivers, challenges, trends, and more.
Some of the key topics covered in the report include:
Market LandscapeMarket ecosystem Market characteristics Market segmentation analysis
Market SizingMarket definition Market size and forecast
Five Forces Analysis
Geographical SegmentationRegional comparison Key leading countries
Vendor LandscapeVendors covered Vendor classification Market positioning of vendors Competitive scenario
is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
If you are interested in more information, please contact our media team at .
View source version on businesswire.com:https://www.businesswire.com/news/home/20181003005845/en/
CONTACT: Technavio Research
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
INDUSTRY KEYWORD: HEALTH MANUFACTURING CHEMICALS/PLASTICS GENERAL HEALTH
SOURCE: Technavio Research
Copyright Business Wire 2018.
PUB: 10/03/2018 03:41 PM/DISC: 10/03/2018 03:41 PM